ZBH
Zimmer BiometDNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
ZBH has primary-source support for an active innovation cycle and a defined April 28, 2026 event that could validate that the sales-force transition is manageable. If execution is clean, the shares have room to move toward and slightly above the packet's $102 median target.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
2026 guidance already leaves limited room for execution misses.
Momentum
25
Value
66
Sentiment
55
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $101.00 · Bull $108.00 · Bear $86.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $102.00
Why
Momentum25 · Δ7d -4.1
Value66 · Δ7d +0.1
Sentiment55 · Δ7d +7.4
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
25
34% active weight
Current posture
7d trendFlat
Δ7d
-4.1
Δ21d
+10.1
Value
66
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.3
Sentiment
55
33% active weight
Current posture
7d trendImproving
Δ7d
+7.4
Δ21d
+3.9
Why this grade
Composite grade D. Momentum 25.4 / Value 65.7 / Sentiment 55.1
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$16.2B
Beta
0.62
Shares Out
198.18M
P/E (TTM)
22.9
P/S (TTM)
2.29
P/FCF (TTM)
19.53
Rev YoY
+9.7%
EPS YoY
-5.3%
Gross Margin
+71.4%
Op Margin
+16.6%
Net Debt
$5.68B
Current Ratio
2.43
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology